Phosphoglucomutase activity as a novel biomarker in patients with acute myocardial infarction

Circulation Journal

Volumn 76, Issue 9, 2012, Pages 2197-2203

  Nishinari, Makoto ^a   Aoyama, Naoyoshi ^a   Ogawa, Zensuke ^b   Yukino, Shogo ^b   Oka, Shusaku ^b   Yano, Kouji ^b   Kurosaki, Yoshifumi ^b   Takeuchi, Ichiro ^a   Imaki, Ryuta ^a   Tojo, Taiki ^a   Shimohama, Takao ^a   Takehana, Hitoshi ^a   Izumi, Tohru ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

Acute myocardial infarction; Phosphoglucomutase activity; ST elevation myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CLOPIDOGREL; CREATINE KINASE; CREATINE KINASE MB; D DIMER; FATTY ACID BINDING PROTEIN; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PENTRAXIN 3; PHOSPHOGLUCOMUTASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL; TROPONIN T;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY STENT; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PILOT STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE ANGINA PECTORIS;

ADULT; AGED; ANGINA, STABLE; ANIMALS; BIOLOGICAL MARKERS; CATTLE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PHOSPHOGLUCOMUTASE; PILOT PROJECTS; THROMBOSIS;

EID: 84865461230     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-1444     Document Type: Article

References (27)

1. Inoue K, Suwa S, Ohta H, Itoh S, Maruyama S, Masuda N, et al. Heart fatty acid-binding protein offers similar diagnostic performance to high-sensitivity troponin T in emergency room patients presenting with chest pain. Circ J 2011; 75: 2813-2820.
2. Sakai T, Inoue S, Takei M, Ogawa G, Hamazaki Y, Ota H, et al. Activated inflammatory cells participate in thrombus size through tissue factor and plasminogen activator inhibitor-1 in acute coronary syndrome: Immunohistochemical analysis. Thromb Res 2011; 127: 443-449.
3. Latini R, Maggioni AP, Peri G, Gonzini L, Lucci D, Mocarelli P, et al. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation 2004; 110: 2349-2354.
4. Empana JP, Canoui-Poitrine F, Luc G, Juhan-Vague I, Morange P, Arveiler D, et al. Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: The PRIME Study. Eur Heart J 2008; 29: 1966-1974.
5. Cori CF, Cori GT. Mechanism of formation of hexosemonophosphate in muscle and isolation of new phosphate ester. Proc Soc Exper Biol Med 1936; 34: 702-705.
6. Kendal LP, Stickland LH. Studies in glycolysis: The first stages of glycolysis in muscle extracts. Biochem J 1938; 32: 572-584.
7. Leloir LF, Trucco RE, Cardini CE, Paladini A, Caputto R. The coenzyme of phosphoglucomutase. Arch Biochem 1948; 19: 339-340.
8. Quick CB, Fisher RA, Harris H. Differentiation of the PGM 2 locus isozymes from those of PGM 1 and PGM 3 in terms of phosphopentomutase activity. Ann Hum Genet 1972; 35: 445-454.
9. McAlpine PJ, Hopkinson DA, Harris H. The relative activities attributable to the three phosphoglucomutase loci (PGM1, PGM2, PGM3) in human tissues. Ann Hum Genet 1970; 34: 169-175.
10. Mann RL, al Kindy AM. Phosphoglucomutase (PGM) grouping of bloodstains on silver. J Forensic Sci 1991; 36: 576-578.
11. Rothwell TJ, Sayce MD. The stability of PGM and AK isoenzymes in human tissues. J Forensic Sci 1974; 19: 590-598.
12. Arimura T, Inagaki N, Hayashi T, Shichi D, Sato A, Hinohara K, et al. Impaired binding of ZASP/Cypher with phosphoglucomutase 1 is associated with dilated cardiomyopathy. Cardiovasc Res 2009; 83: 80-88.
13. Kondoh H, Lleonart ME, Bernard D, Gil J. Protection from oxidative stress by enhanced glycolysis; a possible mechanism of cellular immortalization. Histl Histopathol 2007; 22: 85-90.
14. King J. Phosphoglucomutase. Bergmeyer HU, editor. 1974; VI: 798-801.
15. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351: 1285-1295.
16. Kimura T, Itoh T, Fusazaki T, Matsui H, Sugawara S, Ogino Y, et al. Low-density lipoprotein-cholesterol/high-density lipoprotein-cholesterol ratio predicts lipid-rich coronary plaque in patients with coronary artery disease-integrated-backscatter intravascular ultrasound study. Circ J 2010; 74: 1392-1398.
17. Kashiyama T, Ueda Y, Nemoto T, Wada M, Masumura Y, Matsuo K, et al. Relationship between coronary plaque vulnerability and serum n-3/n-6 polyunsaturated fatty acid ratio. Circ J 2011; 75: 2432-2438.
18. Tani S, Nagao K, Anazawa T, Kawamata H, Furuya S, Fuji T, et al. Association of plasma level of malondialdehyde-modified low-density lipoprotein with coronary plaque morphology in patients with coronary spastic angina: Implication of acute coronary events. Int J Cardiol 2009; 135: 202-206.
19. Orak M, Ustundag M, Guloglu C, Alyan O, Sayhan MB. The role of serum D-dimer level in the diagnosis of patients admitted to the emergency department complaining of chest pain. J Int Med Res 2010; 38: 1772-1779.
20. Ridker PM, Cook NR. Biomarkers for prediction of cardiovascular events. N Engl J Med 2007; 356: 1472-1473.
21. Inoue K, Sugiyama A, Reid PC, Ito Y, Miyauchi K, Mukai S, et al. Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris. Arterioscler Thromb Vasc Biol 2007; 27: 161-167.
22. Pelsers MM, Hanhoff T, Van der Voort D, Arts B, Peters M, Ponds R, et al. Brain-and heart-type fatty acid-binding proteins in the brain: Tissue distribution and clinical utility. Clin Chem 2004; 50: 1568-1575.
23. Suzuki S, Takeishi Y, Niizeki T, Koyama Y, Kitahara T, Sasaki T, et al. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure. Am Heart J 2008; 155: 75-81.
24. Nishinari M, Aoyama N, Zensuke O, Yukino S, Oka S, Kurosaki Y, et al. Clinical state of acute myocardial infarction with increased phosphoglucomutase activity: The relationship between phosphoglucomutase activity and acute thrombosis. J Anal Bio-Sci 2012; 35: 157-167.
25. Hong MK, Mintz GS, Lee CW, Kim YH, Lee SW, Song JM, et al. Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: A three-vessel intravascular ultrasound study in 235 patients. Circulation 2004; 110: 928-933.
26. Shitrit D, Bar-Gil Shitrit A, Rudensky B, Sulkes J, Gutterer N, Zviony D. Role of ELISA D-dimer test in patients with unstable angina pectoris presenting at the emergency department with a normal electrocardiogram. Am J Hematol 2004; 77: 147-150.
27. Liuzzo G, Baisucci LM, Gallimore JR, Caligiuri G, Buffon A, Rebuzzi AG, et al. Enhanced inflammatory response in patients with preinfarction unstable angina. J Am Coll Cardiol 1999; 34: 1696-1703.